BioCentury
ARTICLE | Clinical News

Onco TCS: Began Phase II trials

November 19, 2001 8:00 AM UTC

Inex Pharmaceuticals Corp. (TSE:IEX), Vancouver, B.C. Product: Onco TCS Business: Cancer Therapeutic category: Cytotoxic, Cell proliferation Target: Spindle microtubules Description: Transmembrane Ca...